Relevant evidence may include purity, molecular-weight characterization, endotoxin specification, and antibody-binding activity, depending on the intended assay. Selected ACROBiosystems FCRL5 products include SDS-PAGE, SEC-MALS or HPLC, ELISA, and SPR data, but the validation package differs by catalog number. Researchers should prioritize evidence that matches the planned application rather than assume that every FCRL5 format has the same QC or bioactivity profile.

ACROBiosystems provides recombinant FCRL5 proteins from human, cynomolgus monkey, and mouse. Species selection should reflect the therapeutic candidate's cross-reactivity and the biological model used during development. Construct, tag, and available validation should also be compared across species so that reagent-format differences are not mistaken for species-dependent binding differences.

Yes. Selected ACROBiosystems FCRL5 proteins have been evaluated for anti-FCRL5/CD307e antibody binding using methods such as ELISA, with SPR data also available for specific human products. These data can inform reagent selection for antibody-binding or affinity-assay development. Results should be interpreted for the specific construct, binding partner, and assay conditions tested.

Recombinant FCRL5 products can contain different portions of the extracellular sequence, so proteins with similar tags may not present the same target region. ACROBiosystems provides human FCRL5 proteins with different sequence boundaries, including larger extracellular constructs and selected shorter constructs. Researchers should confirm that the sequence region is appropriate for the antibody epitope or interaction being studied.

Protein format should match the planned immobilization, capture, or detection strategy. His-tagged proteins can support compatible capture or affinity workflows, Fc-tagged formats provide an alternative immobilization configuration, and site-specifically biotinylated Avi-tag proteins can support compatible streptavidin-based assays. Product-specific construct and validation data should also be reviewed because different FCRL5 formats are not necessarily interchangeable.

Start with the species and FCRL5 construct required by the experimental model, then select a tag or labeling format compatible with the planned assay. ACROBiosystems provides FCRL5 proteins in human and selected preclinical species, with product-specific antibody-binding and molecular-characterization data. Reagents should be compared by construct and demonstrated application rather than by tag alone.